Copyright
©The Author(s) 2022.
World J Hepatol. Jul 27, 2022; 14(7): 1480-1494
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1480
Published online Jul 27, 2022. doi: 10.4254/wjh.v14.i7.1480
Figure 2 The value of Mac-2 binding protein and Mac-2 binding protein glycosylation isomer in hepatitis C virus-positive and -negative patients.
A: The values of Mac-2 binding protein in hepatitis C virus (HCV)-negative and -positive groups; B: The values of Mac-2 binding protein glycosylation isomer in HCV-negative and -positive groups. The box charts for the Y-axis indicate the median as bold lines in the boxes, 25th and 75th percentiles as boxes, and 10th and 90th percentiles as lines for each edge. HCV: Hepatitis C virus; M2BPGi: Mac-2 binding protein; M2BPGi: Mac-2 binding protein glycosylation isomer; COI: Cutoff index.
- Citation: Nakai M, Morikawa K, Hosoda S, Yoshida S, Kubo A, Tokuchi Y, Kitagataya T, Yamada R, Ohara M, Sho T, Suda G, Ogawa K, Sakamoto N. Pre-sarcopenia and Mac-2 binding protein glycosylation isomer as predictors of recurrence and prognosis of early-stage hepatocellular carcinoma. World J Hepatol 2022; 14(7): 1480-1494
- URL: https://www.wjgnet.com/1948-5182/full/v14/i7/1480.htm
- DOI: https://dx.doi.org/10.4254/wjh.v14.i7.1480